Ken Griffin PROTEOSTASIS THERAPEUTICS IN Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
N/A
-30,912 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
N/A
-75,650 Reduced 70.99%
30,912 $34,000
Q2 2020

Aug 14, 2020
SELL
N/A
-58,984 Reduced 35.63%
106,562 $146,000
Q1 2020

May 15, 2020
BUY
N/A
57,562 Added 53.31%
165,546 $188,000
Q4 2019

Feb 14, 2020
BUY
N/A
30,317 Added 39.03%
107,984 $246,000
Q3 2019

Nov 14, 2019
SELL
N/A
-44,431 Reduced 36.39%
77,667 $0
Q2 2019

Aug 14, 2019
BUY
N/A
31,140 Added 34.24%
122,098 $119,000
Q1 2019

May 15, 2019
BUY
N/A
73,076 Added 408.66%
90,958 $0
Q4 2018

Feb 14, 2019
SELL
N/A
-5,398 Reduced 23.19%
17,882 $0
Q3 2018

Nov 13, 2018
SELL
N/A
-47,145 Reduced 66.94%
23,280 $0
Q2 2018

Aug 10, 2018
BUY
N/A
70,425 New
70,425 $0
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email